Now a days lot of new treatments and advances in research are giving lots of hopes to people affected by Parkinson’s disease. Parkinson’s stem cell therapy is to help those who has not met clinical needs to achieve optimum health and better quality of life. The quality of life changes in individuals with Parkinson ’s disease through stem cell therapy.

Parkinson ’s disease treatment through stem cell therapy is being studied for efficacy in improving the complications in patients through the use of their own stem cells. This treatment may help patients whose health don’t respond to typical drug treatment and for those who wants to reduce their reliance on medication and for people who wants to try stem cell therapy before starting treatment on medication.

The most of the complications in Parkinson’s patients are related to the failure of dopamine neurons to do their work properly. This dopamine sends signals to the part of brain that controls movement of our body. It allows the muscles to move smoothly and do what you want them to do. If the nerve cells breaks down you no longer have enough dopamine, and you have trouble moving and completing tasks.

This stem cell treatment for Parkinson's disease is exclusively to target these neurons and to help with the creation of new dopamine producing neurons. Additionally the stem cells may release natural chemicals called cytokines which can induce differentiation of the stem cells into dopamine producing neurons.

In recent times stem cell research has the potential to impact the development of disease-modifying treatments for Parkinson's disease, and considerable progress has been made in creating dopamine-producing cells from stem cells. The growth of new cell of Parkinson's disease patient in a particularly in the area of stem cell research, as the current lack of progressive, predictive models of Parkinson's disease remains a major barrier to drug development.

Still, there are so many challenges before stem cell-based cell replacement therapies which has to get over come and then only. There are more work is still needed to generate robust cells, in both quality and quantity, that can also survive and function appropriately in a host brain. Even though ES cells hold great potential, we do not yet know which stem cell type ultimately holds the greatest promise. Hence , researchers require scientific freedom to pursue research on all types -- including ES, adult and IPS cells -- in order to yield results for patients.